Trials / Conditions / Brain Neoplasms, Benign
Brain Neoplasms, Benign
4 registered clinical trials studyying Brain Neoplasms, Benign.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 | Reveal Pharmaceuticals Inc. | Phase 2 |
| Withdrawn | More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery NCT01445691 | Constantinos Hadjipanayis | Phase 2 |
| Completed | Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Bra NCT01151670 | Wake Forest University Health Sciences | Phase 1 |
| Terminated | Risk Factors for Adult-Onset Brain Tumors NCT00592865 | Vanderbilt University Medical Center | — |